search-icon
AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
2
Tenable acquires Sam Altman-backed Apex for over $105 million to boost AI security
3
Guardicore founders raise $32 million for new stealth cyber-AI startup
4
Syte files for court protection after burning through $70 million in funding
5
The 50 most promising Israeli startups - 2025
More news Buzzmore

RedHill Biopharma

2 stories about RedHill Biopharma
גלעד רדאי

Israel’s RedHill Biopharma testing oral pill that cures Covid-19 symptoms

28.02.21|Yafit Ovadia
Israeli pharmaceutical company creates treatment to help severe and moderately-ill patients; company generates $90 million in sales annually
default image

RedHill's Public Offering Spooks Investors, Sends Stock Down

09.11.17|Dror Reich
The Nasdaq-listed biopharmaceutical company priced its shares at $5.5 per American Depositary Share, a third of its 2015 public offering price, and dropped nearly 30% by Wednesday market close
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1